AFP and neoplasm: The predictors in these models can be categorized into those pertaining to the tumor burden, i.e., tumor size, number, and volume; biological tumor aggressiveness, i.e., alpha-fetoprotein (AFP) level and poor pathological tumor characteristics, such as poorly differentiated tumors, microvascular invasion (MVI), and satellite nodules; and liver function reserve [8–14].